MRI-derived radiomics: methodology and clinical applications in the field of pelvic oncology
- PMID: 31538516
- PMCID: PMC6913356
- DOI: 10.1259/bjr.20190105
MRI-derived radiomics: methodology and clinical applications in the field of pelvic oncology
Abstract
Personalized medicine aims at offering optimized treatment options and improved survival for cancer patients based on individual variability. The success of precision medicine depends on robust biomarkers. Recently, the requirement for improved non-biologic biomarkers that reflect tumor biology has emerged and there has been a growing interest in the automatic extraction of quantitative features from medical images, denoted as radiomics. Radiomics as a methodological approach can be applied to any image and most studies have focused on PET, CT, ultrasound, and MRI. Here, we aim to present an overview of the radiomics workflow as well as the major challenges with special emphasis on the use of multiparametric MRI datasets. We then reviewed recent studies on radiomics in the field of pelvic oncology including prostate, cervical, and colorectal cancer.
Figures
References
-
- Lee JH, Lee S-W, Kim JR, Kim YS, Yoon MS, Jeong S, et al. . Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01. Gynecol Oncol 2017; 147: 577–84. doi: 10.1016/j.ygyno.2017.09.036 - DOI - PubMed
-
- Avanzo M, Stancanello J. El Naqa I: Beyond imaging: The promise of radiomics. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics 2017; 38: 122–39. - PubMed